Brief Report: Aspirin Ingestion Compared with Bleeding Disorders—Search for a Useful Platelet Antiaggregant

WEISS, HARVEY J.

doi:10.1182/blood.V35.3.333.333

HARVEY J. WEISS, M.D.

Formerly, Assistant Professor of Medicine

1Department of Medicine (Hematology), The Mt. Sinai School of Medicine of the City University of New York, New York, N.Y.

2the Mt. Sinai School of Medicine, New York, N. Y.; presently, Associate Clinical Professor of Medicine, Columbia University College of Physicians and Surgeons, New York, N. Y. and Director Division of Hematology, Roosevelt Hospital, New York, N. Y. Recipient of a Career Scientist Award from the Health Research Council of time City of New York.

Search for other works by this author on:

This Site

PubMed

Google Scholar

Blood (1970) 35 (3): 333–340.

https://doi.org/10.1182/blood.V35.3.333.333

Abstract

The effects on human platelets produced by ingesting aspirin have been compared with the types of platelet abnormalities observed in patients with bleeding disorders. The inhibitory effect of aspirin on platelet function appears to be relatively weak and suggests a continued search for antiaggregant agents which may prove to be useful in preventing thrombosis.

This content is only available as a PDF.

1970

Brief Report: Aspirin Ingestion Compared with Bleeding Disorders—Search for a Useful Platelet Antiaggregant

Abstract

Contents

Data & Figures

Supplemental data

References

Cited By

Email alerts

ASH Publications

American Society of Hematology

Brief Report: Aspirin Ingestion Compared with Bleeding Disorders—Search for a Useful Platelet Antiaggregant

Abstract

Contents

Data & Figures

Supplemental data

References

Related

Related

Cited By

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only